Updated: January 26, 2026
How Does Lysodren Work? Mechanism of Action Explained in Plain English
Author
Peter Daggett

Summarize with AI
Lysodren (mitotane) destroys adrenal cortex cells and blocks hormone production. Here's how it works, why it takes months to reach therapeutic levels, and why monitoring is critical.
Lysodren (mitotane) works in a way that is unlike most cancer medications. Rather than killing all rapidly dividing cells (like traditional chemotherapy), it targets one specific organ — the adrenal cortex — and destroys it. Understanding how this works helps patients and caregivers make sense of the unusual dosing requirements, the months-long titration process, and the need for lifelong hormone replacement. Let's break it down in plain language.
What Is the Adrenal Cortex?
The adrenal glands are two small, hat-shaped organs that sit on top of the kidneys. Each gland has two parts: an inner core called the medulla, and an outer shell called the cortex. The adrenal cortex produces essential steroid hormones, including:
Cortisol — the "stress hormone" that regulates metabolism, immune function, and the body's response to illness and injury
Aldosterone — regulates blood pressure and electrolytes
Sex hormones — including androgens (like DHEA) and small amounts of estrogen
Adrenocortical carcinoma (ACC) is a cancer that starts in these cortex cells. In functional ACC tumors, the cancer cells still produce these hormones — but uncontrollably, in amounts that cause serious symptoms.
How Does Lysodren Work? The Two-Part Attack
Lysodren (mitotane) attacks adrenal cortex cells in two complementary ways:
Adrenal cytotoxicity (cell killing): Mitotane is metabolized inside adrenal cortex cells into a reactive compound that damages the cells directly. The exact mechanism is not fully understood, but oxidative damage and metabolic disruption within the tumor cells are thought to play a role. This is what makes mitotane a cytotoxic (cell-killing) cancer drug — it preferentially destroys adrenal cortex tissue.
Steroidogenesis inhibition (blocking hormone production): Mitotane also inhibits key enzymes in the adrenal steroid production pathway — particularly StAR (steroidogenic acute regulatory protein) and CYP11A1 (cholesterol side-chain cleavage enzyme). By targeting these enzymes, mitotane blocks the adrenal cortex from making cortisol and other hormones. This is particularly important in functional ACC, where uncontrolled hormone production causes severe symptoms.
This dual action — killing tumor cells AND blocking their hormone output — is what makes Lysodren uniquely valuable. No other approved drug does both.
Why Does Lysodren Take So Long to Work?
One of the most common questions patients have is: why does it take 3 to 5 months to reach therapeutic levels? The answer lies in Lysodren's unique pharmacology.
Mitotane is highly lipophilic — it dissolves readily in fat and accumulates in adipose (fat) tissue throughout the body. As the drug is absorbed after each dose, it distributes widely into fat stores. The body then slowly releases mitotane back into the bloodstream from these fat reservoirs.
The result is an extremely long half-life of 18 to 159 days. Reaching a steady-state plasma concentration takes 5 or more half-lives — which is why therapeutic plasma levels of 14–20 mg/L typically require 3 to 5 months of dosing to achieve.
Importantly: even after the dose is held constant, plasma levels may still rise — because fat tissue continues releasing the drug. This is why monitoring blood levels every 2 weeks during titration is critical, and why levels can spike unexpectedly even without a dose change.
How Lysodren Affects the Rest of the Body
Because Lysodren works by destroying adrenal tissue, it produces effects throughout the body that go beyond the tumor:
Adrenal insufficiency: As the adrenal cortex is damaged, cortisol production falls. All patients on Lysodren need supplemental steroids (hydrocortisone) to prevent adrenal crisis.
CYP3A4 induction: Mitotane is a strong inducer of the liver enzyme CYP3A4, which metabolizes hundreds of other drugs. This means Lysodren can dramatically reduce the effectiveness of many medications — including hormonal contraceptives, warfarin, some antidepressants, and cancer drugs like sunitinib.
CNS effects: Mitotane crosses the blood-brain barrier and accumulates in brain tissue. At therapeutic levels, it causes dizziness, mental sluggishness, and fatigue. At toxic levels (>20 mg/L), severe neurotoxicity can occur, including sedation, memory loss, and coordination problems.
Hormonal disruption: By suppressing steroidogenesis, Lysodren can reduce thyroid hormones, testosterone (in men), and cholesterol metabolism — requiring monitoring and sometimes treatment for these effects.
Why Is Lysodren Related to DDT?
Mitotane's chemical structure is derived from DDT, the once-widely-used insecticide. Researchers in the 1940s and 1950s discovered that DDT and its metabolites caused adrenal cortex damage in test animals. This observation led to the development of o,p'-DDD (mitotane) as a targeted adrenal cytotoxin. It's a striking example of how unexpected chemical properties can lead to medical treatments.
The Takeaway: Lysodren Is a Unique and Complex Drug
Lysodren works by selectively destroying adrenal cortex tissue and blocking hormone production — a dual mechanism that no other approved drug replicates. Its extreme lipophilicity, long half-life, and need for precise therapeutic monitoring make it unlike any other cancer medication. Understanding how it works helps patients and families make sense of the treatment experience. If you're having trouble accessing Lysodren, medfinder can help locate a specialty pharmacy near you.
See also: What Is Lysodren? Uses, Dosage, and What You Need to Know in 2026.
Frequently Asked Questions
Lysodren works through two mechanisms: it directly destroys adrenal cortex cells (cytotoxicity), and it blocks steroid hormone production by inhibiting key enzymes in the adrenal steroid synthesis pathway (including StAR and CYP11A1). This dual action makes it both a cancer treatment and a hormone-control agent in functional adrenocortical carcinoma.
Lysodren (mitotane) is highly lipophilic — it dissolves in fat and accumulates in adipose tissue throughout the body. It has an extremely long half-life of 18 to 159 days. Because steady-state levels require multiple half-lives to achieve, it typically takes 3 to 5 months of consistent dosing to reach the therapeutic plasma target of 14–20 mg/L.
Lysodren is a strong inducer of CYP3A4, a liver enzyme that metabolizes hundreds of drugs. By dramatically speeding up CYP3A4 activity, mitotane causes the body to break down many other medications faster than normal — reducing their effectiveness. This affects drugs like warfarin, hormonal contraceptives, and many cancer drugs. Always review your full medication list with your oncologist.
Yes. Because Lysodren works by destroying adrenal cortex tissue, it causes adrenal insufficiency (inadequate cortisol production) in virtually all patients. Adrenal steroid replacement therapy — typically hydrocortisone plus fludrocortisone — is required for essentially every Lysodren patient. This replacement must continue during and after treatment.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Lysodren also looked for:
More about Lysodren
36,837 have already found their meds with Medfinder.
Start your search today.





